Hoste, Griet http://orcid.org/0000-0002-4331-8663
Slembrouck, Laurence
Jongen, Lynn
Punie, Kevin
Matton, Tom
Vander Borght, Sara
Vanden Bempt, Isabelle
Menten, Johan
Wildiers, Hans
Floris, Giuseppe
Arteaga, Carlos
Neven, Patrick
Article History
First Online: 5 September 2018
Change Date: 12 January 2019
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40261-019-00748-x
Compliance with Ethical Standards
:
: The study was conducted in compliance with the principles of the Declaration of Helsinki (2008), the principles of GCP and in accordance with all applicable regulatory requirements. The study was approved by our Ethics Committee and the patient gave written informed consent.
: The patient gave written consent for publication.
: The authors declare that they have no competing interests.
: Novartis Belgium provided the patient with free samples of BYL-179 (oral alpelisib) and AstraZeneca Belgium provided fulvestrant.